• Home
  • |
  • Study Request
  • |
  • Useful Links
  • |
  • Contact us
  • About GRC
  • Accreditation
  • Clients and Sponsors
  • Available Assays
  • Electronic Consent
  • Career Opportunities
  • Bioequivalence Studies
  • Clinical Trial (Phase II – IV)
  • Accelerated Stability Studies
  • In-vitro Dissolution Studies

Useful Links

EGYPT LINKS

  • The Ministry of Health and Population
  • Egyptian Medical Syndicate
  • World Health Organization - Regional Office for the Eastern Mediterranean
  • Egyptian Pharmacists Syndicate
  • Egyptian drug agency



FDA REGULATIONS

  • U.S. Food and Drug Administration
  • Institutional Reiew Boards
  • Protection of Human Subjects; Informed Consent
  • FDA Individual Product Bioequivalence Recommendations
  • Bioavailability & Bioequivalence Requirements
  • Dissolution Methods for Drug Products
  • Protection of Human Subjects
  • Institutional Review Boards
  • Bioavailability and Bioequivalence Requirements
  • International guidelines



CLINICAL TRIALS & GCP LINKS

  • ICH
  • GCP EC
  • Good Clinical Practice: FDA Consolidated Guidance
  • Clinical Safety Data Management Definitions and Standards for Expedited Reporting
  • Structure and Content of Clinical Study Reports - FDA
  • Structure and Content of Clinical Study Reports - EMEA
  • Financial Disclosure by Clinical Investigators
  • Electronic Records; Electronic Signatures
  • Guideline for Monitoring Clinical Investigations
  • Clinicaltrials.gov
  • Cancer.gov
  • Centerwatch.com



REGIONAL BIOEQUIVALENCE REQUIREMENTS LINKS

  • www.eda.mohp.gov.eg
  • Saudi Arabia
  • Gulf Countries GCC
  • SGH
  • GCC Bioequivalence requirements
  • Saudi Arabia, Ministry of Health
  • Saudi Arabia Bioequivalence requirements
  • UAE Ministry of Health
  • Kuwait Ministry of Health
  • Bahrain Ministry of Health
  • Qatar Ministry of Health
  • Yemen Ministry of Health
  • Oman Ministry of Health
  • Jordan Ministry of Health
  • Jordan JFDA
All Copyrights Reserved to GRC®, 2011 Created by ICONS
  • GRC Profile
  • Excutive Team
  • Vision & Mission
  • Bioanalytical
  • Clinical Services
  • PK/PD & Biostatistics
  • Quality Assurance
  • Information System
  • Biowaivers and comparative in-vitro dissolution
  • Development & analytical method validation
  • Solid container 6 months at 40 C/75% R.H.
  • Semipermeable containers for 6 months at 40 C/75%R.H.
  • Clinical Trials Management
  • Data Management
  • Studies Services
  • Available Assays
  • Clients & Sponsors
  • Our Parteners
  • Vacancies
  • Application Form